COMMUNIQUÉS West-GlobeNewswire

Lumere Lands on Crain’s “2019 Best Places to Work in Chicago” List
11/03/2019
CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- Lumere, Inc., a leading provider of evidence-based analytics and services to reduce costly and unwarranted variation in drugs and medical devices, has been named one of the [...]
HOOPP 2018 Results: Delivering on the pension promise to our members
11/03/2019
Funded status is 121% and net assets increased to $79B TORONTO, March 11, 2019 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) announced today that its net assets reached $79.0 billion at the end of [...]
ActivX Biosciences reports key findings that could impact the use of clinically approved CDK4/6 inhibitors in the treatment of cancer patients
11/03/2019
LA JOLLA, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces a report published in a high profile, peer-reviewed journal [...]
Resverlogix Announces Participation at Prominent Industry and Investor Conferences
11/03/2019
CALGARY, Alberta, March 11, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) announced today its participation at leading industry and investor conferences during the month of March [...]
5 Influential Companies In CBD-Infused Beverages
11/03/2019
VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- As consumer awareness around CBD continues to grow, cannabis companies are beginning to allocate an inordinate amount of investment capital into the [...]
Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada
11/03/2019
VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that its streaming partner, Lotus Ventures Inc. (“ Lotus ”), has [...]
Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal
11/03/2019
Zug, Switzerland, March 11, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
CORRECTION - Exactus Announces Agricultural Diversification with Entry Into 200 Acre Farming Project for 2019 Grow Season – Promotion of Emiliano Aloi as President
11/03/2019
“Exactus One World” Heralds Fully Diversified Strategy and Propels Exactus to Forefront of Rapidly Evolving CBD Industry GLEN ALLEN, Va., March 11, 2019 (GLOBE NEWSWIRE) -- This release corrects and replaces the version [...]
Precipio CEO Issues Shareholder Update Letter
11/03/2019
NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), issues the following letter from CEO Ilan Danieli. Dear Shareholders, Following our recent quarterly [...]
Share buy-back week 10/2019
11/03/2019
Announcement 11 March 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Novo Nordisk A/S - Share repurchase programme
11/03/2019
Bagsværd, Denmark, 11 March 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University
11/03/2019
Groundbreaking GDF15 biomarker may be the first single examination to accurately predict disease progression NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( QBIO ), a commercial stage biotechnology [...]
Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting
11/03/2019
NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day
11/03/2019
BASKING RIDGE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the [...]
Menlo Therapeutics to Present at the 31st Annual ROTH Conference
11/03/2019
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
Ultragenyx to Present at Upcoming Investor Conferences
11/03/2019
NOVATO, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Cocrystal Pharma Announces Closing of Private Placement
11/03/2019
BOTHELL, WA, March 11, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, [...]
First patient dosed in a Phase 2 study with LiPlaCis in prostate cancer
11/03/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, March 11, 2019 – Oncology Venture A/S (“OV” or “the Company”) today announced that the first patient has been dosed in a Phase 2 study with LiPlaCis ® in prostate [...]
Merus to Present at the Cowen & Co. 39th Annual Health Care Conference
11/03/2019
UTRECHT, Netherlands, March 11, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]

Pages